Skip to content
OpenCapital
Get started

CBL & Associates Properties CBL Available for sale investments

Available for sale investments at other companies

Aflac logo
AflacAFL
$63.23B-5.8%
Apollo Global Management logo
Apollo Global ManagementAPO
$219.47B+11.7%
Agilon Health logo
Agilon HealthAGL
$91.42M-60.3%
Popular logo
PopularBPOP
$21.7B+11.5%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$469.54M-0.9%
Horace Mann Educators logo
Horace Mann EducatorsHMN
$5.78B+5.9%

Other financials

Income statement

See full
Revenue$146.0M+3.0%
Net income$46.5M+429%
EPS (diluted)$1.48+448%

Balance sheet

See full
Cash & equivalents$122.7M+312%
Total debt$4.2B+94.4%
Total equity$398.0M+34.9%
Total assets$2.6B+0.8%

Cash flow

See full
Operating cash flow$52.9M+67.0%

Valuation

See full
Market cap$1.58B+44.8%

Profitability

See full
Operating margin21%—
Net margin29.8%+17.0pp

Returns & leverage

See full
Return on equity50.1%+28.3pp
Debt / equity10.5×+3.2×

Where this comes from

Reported directly by CBL & Associates Properties in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: CBL & Associates Properties’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CBL & Associates Properties's available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CBL & Associates Properties's available for sale investments?
CBL & Associates Properties (CBL) reported available for sale investments of $160.27M in Q1 2026.
How has CBL & Associates Properties's available for sale investments changed year-over-year?
CBL & Associates Properties's available for sale investments decreased by 34.9% year-over-year, from $246.29M to $160.27M.
What is the long-term trend for CBL & Associates Properties's available for sale investments?
Over 5 years (2020 to 2025), CBL & Associates Properties's available for sale investments has grown at a 4.7% compound annual growth rate (CAGR), from $233.07M to $293.09M.